共 50 条
- [1] ADDRESSING SYSTEMIC BARRIERS FOR THE USE OF LONG-ACTING INJECTABLES IN EARLY PSYCHOSIS JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S44 - S44
- [3] LONG-ACTING INJECTABLES AND PEDIATRIC PSYCHOTIC DISORDERS JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (10): : S74 - S74
- [4] LONG-ACTING INJECTABLES AND PEDIATRIC PSYCHOTIC DISORDERS JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2024, 63 (10): : S122 - S122
- [5] LONG-ACTING INJECTABLES AND PEDIATRIC PSYCHOTIC DISORDERS JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S110 - S110
- [7] The relevance of long-acting injectables in the treatment of schizophrenia LANCET PSYCHIATRY, 2023, 10 (03): : 159 - 160
- [8] Inspirational chemistry of bioabsorbable long-acting injectables Drug Delivery and Translational Research, 2023, 13 : 371 - 377
- [9] Short-acting antipsychotics or long-acting injectables? A treatment comparison in patients with schizophrenia GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2020, 25 (03): : 170 - 178
- [10] Long-acting injectable ART for HIV: a (cautious) step forward LANCET MICROBE, 2022, 3 (02): : E94 - E94